• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项比较数字乳腺断层合成与数字乳腺摄影的随机对照试验中的乳腺钼靶特征及筛查结果

Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography.

作者信息

Aase H S, Danielsen A S, Hoff S R, Holen Å S, Haldorsen I S, Hovda T, Hanestad B, Sandvik C K, Hofvind S

机构信息

Department of Radiology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, 5020, Bergen, Norway.

Section for Breast Cancer Screening, Cancer Registry of Norway, Oslo, Norway; Norwegian Institute of Public Health, Oslo, Norway.

出版信息

Eur J Radiol. 2021 Aug;141:109753. doi: 10.1016/j.ejrad.2021.109753. Epub 2021 May 5.

DOI:10.1016/j.ejrad.2021.109753
PMID:34053786
Abstract

PURPOSE

To compare the distribution of mammographic features among women recalled for further assessment after screening with digital breast tomosynthesis (DBT) versus digital mammography (DM), and to assess associations between features and final outcome of the screening, including immunohistochemical subtypes of the tumour.

METHODS

This randomized controlled trial was performed in Bergen, Norway, and included 28,749 women, of which 1015 were recalled due to mammographic findings. Mammographic features were classified according to a modified BI-RADS-scale. The distribution were compared using 95 % confidence intervals (CI).

RESULTS

Asymmetry was the most common feature of all recalls, 24.3 % (108/444) for DBT and 38.9 % (222/571) for DM. Spiculated mass was most common for breast cancer after screening with DBT (36.8 %, 35/95, 95 %CI: 27.2-47.4) while calcifications (23.0 %, 20/87, 95 %CI: 14.6-33.2) was the most frequent after DM. Among women screened with DBT, 0.13 % (95 %CI: 0.08-0.21) had benign outcome after recall due to indistinct mass while the percentage was 0.28 % (95 %CI: 0.20-0.38) for DM. The distributions were 0.70 % (95 %CI: 0.57-0.85) versus 1.46 % (95 %CI: 1.27-1.67) for asymmetry and 0.24 % (95 %CI: 0.16-0.33) versus 0.54 % (95 %CI: 0.43-0.68) for obscured mass, among women screened with DBT versus DM, respectively. Spiculated mass was the most common feature among women diagnosed with non-luminal A-like cancer after DBT and after DM.

CONCLUSIONS

Spiculated mass was the dominant feature for breast cancer among women screened with DBT while calcifications was the most frequent feature for DM. Further studies exploring the clinical relevance of mammographic features visible particularly on DBT are warranted.

摘要

目的

比较经数字乳腺断层合成(DBT)与数字乳腺X线摄影(DM)筛查后被召回做进一步评估的女性中乳腺X线特征的分布情况,并评估这些特征与筛查最终结果之间的关联,包括肿瘤的免疫组织化学亚型。

方法

这项随机对照试验在挪威卑尔根进行,纳入了28749名女性,其中1015名因乳腺X线检查结果被召回。乳腺X线特征根据改良的乳腺影像报告和数据系统(BI-RADS)分级进行分类。使用95%置信区间(CI)比较分布情况。

结果

不对称是所有召回病例中最常见的特征,DBT组为24.3%(108/444),DM组为38.9%(222/571)。经DBT筛查后,毛刺状肿块是乳腺癌最常见的特征(36.8%,35/95,95%CI:27.2 - 47.4),而经DM筛查后钙化是最常见的特征(23.0%,20/87,95%CI:14.6 - 33.2)。在经DBT筛查的女性中,因肿块不清晰被召回后0.13%(95%CI:0.08 - 0.21)为良性结果,而DM组这一比例为0.28%(95%CI:0.20 - 0.38)。DBT组和DM组筛查的女性中,不对称的分布分别为0.70%(95%CI:0.57 - 0.85)和1.46%(95%CI:1.27 - 1.67),模糊肿块的分布分别为0.24%(95%CI:0.16 - 0.33)和0.54%(95%CI:0.43 - 0.68)。毛刺状肿块是经DBT和DM筛查后被诊断为非腔面A型样癌症的女性中最常见的特征。

结论

经DBT筛查的女性中,毛刺状肿块是乳腺癌的主要特征,而经DM筛查的女性中钙化是最常见的特征。有必要进一步研究探索尤其在DBT上可见的乳腺X线特征的临床相关性。

相似文献

1
Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography.一项比较数字乳腺断层合成与数字乳腺摄影的随机对照试验中的乳腺钼靶特征及筛查结果
Eur J Radiol. 2021 Aug;141:109753. doi: 10.1016/j.ejrad.2021.109753. Epub 2021 May 5.
2
Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening.数字乳腺断层合成与数字乳腺钼靶筛查比较的随机对照试验中间期和后续乳腺癌。
Radiology. 2021 Jul;300(1):66-76. doi: 10.1148/radiol.2021203936. Epub 2021 May 11.
3
A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.一项基于人群的卑尔根筛查中数字乳腺断层合成与数字乳腺钼靶摄影的随机对照试验:To-Be 试验的性能指标中期分析。
Eur Radiol. 2019 Mar;29(3):1175-1186. doi: 10.1007/s00330-018-5690-x. Epub 2018 Aug 29.
4
Digital Mammography versus Digital Mammography Plus Tomosynthesis for Breast Cancer Screening: The Reggio Emilia Tomosynthesis Randomized Trial.数字乳腺 X 线摄影与数字乳腺 X 线摄影加断层合成技术用于乳腺癌筛查的比较:雷焦艾米利亚断层合成随机试验。
Radiology. 2018 Aug;288(2):375-385. doi: 10.1148/radiol.2018172119. Epub 2018 Jun 5.
5
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial.在一项随机对照试验中,通过自动乳腺密度比较数字乳腺断层合成和数字乳腺 X 线摄影的筛查结果:来自 To-Be 试验的结果。
Radiology. 2020 Dec;297(3):522-531. doi: 10.1148/radiol.2020201150. Epub 2020 Sep 15.
6
Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program.数字乳腺断层合成摄影术和数字乳腺钼靶摄影与数字乳腺钼靶摄影的比较:基于人群的筛查计划中的评估。
Radiology. 2018 Jun;287(3):787-794. doi: 10.1148/radiol.2018171361. Epub 2018 Mar 1.
7
Assessment of screen-recalled abnormalities for digital breast tomosynthesis versus digital mammography screening in the BreastScreen Maroondah trial.在乳腺筛查马鲁当试验中,对数字乳腺断层合成与数字乳腺X线摄影筛查的屏幕召回异常情况进行评估。
J Med Imaging Radiat Oncol. 2023 Apr;67(3):242-251. doi: 10.1111/1754-9485.13452. Epub 2022 Jun 29.
8
Discordant and false-negative interpretations at digital breast tomosynthesis in the prospective Oslo Tomosynthesis Screening Trial (OTST) using independent double reading.前瞻性奥斯陆断层合成筛查试验(OTST)中使用独立双读时数字乳腺断层合成的不一致和假阴性解读。
Eur Radiol. 2024 Jun;34(6):3912-3923. doi: 10.1007/s00330-023-10400-0. Epub 2023 Nov 8.
9
10
Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.基于人群的筛查项目中数字乳腺断层合成摄影与标准数字乳腺钼靶摄影连续检查的筛查结果。
Eur Radiol. 2019 Dec;29(12):6991-6999. doi: 10.1007/s00330-019-06264-y. Epub 2019 Jun 11.

引用本文的文献

1
Design considerations and challenges in the CHinA National CancEr Screening (CHANCES) trial and Tomosynthesis Mammographic Imaging Screening Trial (TMIST).中国国家癌症筛查(CHANCES)试验和乳腺断层合成钼靶成像筛查试验(TMIST)中的设计考量与挑战。
J Natl Cancer Inst Monogr. 2025 Mar 1;2025(68):42-48. doi: 10.1093/jncimonographs/lgae049.
2
Cancers not detected in one-view breast tomosynthesis screening-characteristics and reasons for non-detection.在单视图乳腺断层合成筛查中未检测出的癌症——特征及未被检测出的原因。
Eur Radiol. 2024 Dec 20. doi: 10.1007/s00330-024-11278-2.
3
Comparison of Full-Field Digital Mammography with Synthesized Mammography from Tomosynthesis in a Diagnostic population: Prospective Study.
全视野数字乳腺摄影与断层合成乳腺摄影合成图像在诊断人群中的比较:前瞻性研究
Indian J Radiol Imaging. 2024 Aug 1;35(1):25-34. doi: 10.1055/s-0044-1788606. eCollection 2025 Jan.
4
Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.在挪威乳房 X 光筛查 1996-2020 年间,患有浸润性筛检发现的癌症的女性的乳房 X 光特征与乳腺癌死亡风险。
Eur Radiol. 2024 May;34(5):3364-3374. doi: 10.1007/s00330-023-10369-w. Epub 2023 Nov 8.
5
False-positive recalls in the prospective Malmö Breast Tomosynthesis Screening Trial.前瞻性马尔默乳房断层合成筛查试验中的假阳性召回。
Eur Radiol. 2023 Nov;33(11):8089-8099. doi: 10.1007/s00330-023-09705-x. Epub 2023 May 5.
6
Phase-Sensitive Breast Tomosynthesis May Address Shortcomings of Digital Breast Tomosynthesis.相敏乳腺断层合成术可能解决数字乳腺断层合成术的缺点。
Radiology. 2023 Feb;306(2):e222184. doi: 10.1148/radiol.222184. Epub 2022 Sep 27.